Lunit INSIGHT DBT (AI for digital breast tomosynthesis)
2025-11-29https://doi.org/10.1148/atlas.1764445131535
52
Overview
Schema Version
https://atlas.rsna.org/schemas/2025-11/model.json
Name
Lunit INSIGHT DBT (AI for digital breast tomosynthesis)
Link
https://dx.doi.org/10.1148/ryai.230318
Indexing
Keywords: Breast, Computer-Aided Diagnosis (CAD), Tomosynthesis, Artificial Intelligence, Digital Breast Tomosynthesis, Breast Cancer, Computer-Aided Detection, Screening
Content: BR
RadLex: RID10359, RID45682, RID39055, RID34367, RID10357
SNOMED: 254837009
Author(s)
Eun Kyung Park
SooYoung Kwak
Weonsuk Lee
Joon Suk Choi
Thijs Kooi
Eun-Kyung Kim
Organization(s)
Lunit
Department of Radiology, Yongin Severance Hospital, College of Medicine, Yonsei University
Version
1.0
Contact
moc.liamg@1001krape
Funding
This work was supported by funds secured by Lunit.
Ethical review
Retrospective study approved by ethics review and the central institutional review board; requirement for informed consent was waived.
Date
Updated: 2024-02-28
Published: 2024-04-03
Created: 2023-08-14
References
[1] Park EK, Kwak SY, Lee W, Choi JS, Kooi T, Kim E-K. "Impact of AI for Digital Breast Tomosynthesis on Breast Cancer Detection and Interpretation Time". Radiology: Artificial Intelligence. 2024 May;6(3):e230318. . doi:10.1148/ryai.230318. PMID: 38568095. PMCID: PMC11140510.
Model
Architecture
Deep convolutional neural network (CNN) with a ResNet-34 backbone; trained using neighboring DBT sections around annotated lesions; three-stage pipeline (preprocessing, image analysis, result presentation).
Availability
Proprietary diagnostic support software referred to as Lunit INSIGHT DBT.
Clinical benefit
Improves diagnostic accuracy for breast cancer detection on DBT and reduces radiologist reading time; increases interreader agreement.
Clinical workflow phase
Clinical decision support systems during image interpretation (DBT reading).
Decision threshold
Operating cutoff set on tuning dataset to achieve 90% sensitivity; per-mammogram abnormality score defined as the maximum across the four views used for evaluation.
Degree of automation
Assistive decision support; provides heatmaps and abnormality scores to support radiologist decision-making.
Indications for use
Detection and diagnosis support for breast cancer in women undergoing screening or diagnostic digital breast tomosynthesis (four-view exams; female patients aged ≥22 years) in clinical imaging environments.
Input
Four-view DBT examinations (RCC, RMLO, LCC, LMLO) acquired on Hologic and GE HealthCare systems; with full-field DM or synthetic 2D images available for display alongside 3D sections.
Instructions
The system analyzes input DBT images after cropping/resizing and outputs heatmaps and per-lesion/per-breast abnormality scores; results are presented on DBT slices with a slice navigation bar and corresponding synthetic 2D images within PACS or a dedicated in-app viewer.
Limitations
Reader study used a cancer-enriched dataset; potential laboratory effect; performance differences across lesion types (lower for calcification-only lesions) and vendors; development data contained fewer GE than Hologic cases; system analyzes single examinations without prior studies; limited evaluation for some subgroups.
Output
CDEs: RDE2669, RDE1550
Description: Heatmaps/contour marks localizing suspicious lesions on DBT slices and corresponding synthetic 2D images; per-lesion and per-breast abnormality scores; per-mammogram abnormality score.
Recommendation
Use concurrently with radiologists during DBT interpretation to improve accuracy and efficiency.
Use
Intended: Decision support
User
Intended: Radiologist